ZYNESP 100 INJ/ ZYNESP 200 INJ
Free
Composition
DARBEPOETIN ALFA
Zynesp Injection belongs to the class of medication called ‘blood-forming agent’ primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells’ cancer). Zynesp Injection helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn’t filter the blood, leading to anaemia.
Zynesp Injection contains a protein ‘Darbepoetin alfa’ which works by providing signals to the bone marrow to make more red blood cells. Zynesp Injection is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient ‘erythropoietin protein’ which aids in the formation of red blood cells, Zynesp Injection stimulates the production of this protein in the bone marrow.
